JAVIER
CORTES CASTAN
PROFESOR
Pfizer (United States)
Nueva York, Estados UnidosPublications en collaboration avec des chercheurs de Pfizer (United States) (4)
2021
-
The efficacy and safety of enzalutamide with trastuzumab in patients with HER2+ and androgen receptor-positive metastatic or locally advanced breast cancer
Breast Cancer Research and Treatment, Vol. 187, Núm. 1, pp. 155-165
2014
-
Safety and efficacy of neratinib in combination with capecitabine in patients with metastatic human epidermal growth factor receptor 2-positive breast cancer
Journal of Clinical Oncology, Vol. 32, Núm. 32, pp. 3626-3634
2013
-
Randomized phase II study of sunitinib versus standard of care forpatients with previously treated advanced triple-negative breastcancer
Breast, Vol. 22, Núm. 5, pp. 650-656
2012
-
First-line treatment of advanced breast cancer with sunitinib in combination with docetaxel versus docetaxel alone: Results of a prospective, randomized phase III study
Journal of Clinical Oncology, Vol. 30, Núm. 9, pp. 921-929